In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ApniCure Inc.

www.apnicure.com

Latest From ApniCure Inc.

Medical Device Deals Update, May 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced March-April 2016.

Medical Device

Venture Funding Deals, May 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced March through April 2016.

BioPharmaceutical Medical Device

Obstructive Sleep Apnea: CPAP Under Pressure As New Market Segments Awaken

An estimated 15 million Americans have obstructive sleep apnea severe enough to warrant treatment, but this field has been chronically underserved by traditional continuous positive airway pressure systems that are inconvenient and uncomfortable to use. To address this problem, CPAP manufacturers are making design improvements to optimize comfort and compliance; at the same time, promising new technologies are emerging – including neurostimulation devices for OSA – that could help reshape the future management of this often overlooked, but serious disorder.

Medical Device

ApniCure: Unmasking Sleep Therapy With An Alternative To CPAP

Sleep apnea is now widely recognized as an underlying factor for major CV diseases and metabolic disorders, making it a huge market opportunity. ApniCure hopes that by avoiding the CPAP masks that patients hate while using the differential pressure therapy that doctors and payors like, it can unlock this potential blockbuster market.

Medical Device United States
See All

Company Information

  • Industry
  • Medical Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ApniCure Inc.
  • Senior Management
  • Steve Carlson, Pres. & CEO
    Jonathan Podmore, VP, R&D
    David P White, MD, CMO
    Byron Braun, National Sales Dir.
  • Contact Info
  • ApniCure Inc.
    Phone: (650) 361-9300
    900 Chesapeake Dr.
    Redwood City, CA 94063
    USA
UsernamePublicRestriction

Register